Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
Clinical trial NCT04604132 · TERMINATED
Trial details
- NCT number
- NCT04604132
- Sponsor
- Basilea Pharmaceutica
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-06
- Primary completion
- 2022-11-21
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.